Rare gene variants may multiply Alzheimer's disease risk
Alzheimer's disease is the most common form of dementia worldwide, and its development is influenced by a combination of genetic and environmental factors. In recent years, the PLCG2 gene and its encoded enzyme, PLCγ2, have emerged as some of the most important modifiers of Alzheimer's disease risk, as certain genetic variants in the gene appear to protect against the disease. For example, the…
Recent research has revealed that specific gene variants, particularly in the PLCG2 gene, may significantly increase the risk of developing Alzheimer's disease. Alzheimer's is the most prevalent form of dementia globally, and its development is affected by both genetic and environmental elements. In recent years, the PLCG2 gene and its enzyme PLCγ2 have become crucial factors in understanding the risk of Alzheimer's.
Researchers from the University of Eastern Finland and the French INSERM institute conducted a study in Nature Genetics, examining the impact of PLCG2 genetic variants on neuronal function. They found that rare, loss-of-function PLCG2 variants are linked to a tenfold higher risk of Alzheimer's disease compared to individuals without these variants.
The study also demonstrated that impaired PLCγ2 expression in human stem cell-derived neurons led to alterations in dendritic architecture and weakened synaptic function. Synapses, the connections between neurons, are particularly vulnerable in Alzheimer's disease, and synaptic dysfunction is one of the earliest signs of the condition. Additionally, reduced PLCγ2 activity resulted in increased levels of beta-amyloid and tau protein phosphorylation, two primary pathological indicators of Alzheimer's disease.
The research challenges the common belief that PLCG2 primarily influences Alzheimer's risk through its role in microglial cells, the brain's immune cells. Instead, the findings suggest that PLCγ2 is essential in neurons, and its reduced activity may initiate several molecular pathways that contribute to disease progression.
This investigation strengthens the understanding of PLCG2's role in Alzheimer's disease risk and offers valuable insights into the biological mechanisms behind the condition. The study indicates that increasing PLCγ2 signaling could potentially serve as a novel strategy for preventing or treating Alzheimer's disease in the future. However, further research and clinical validation are necessary to confirm these findings and explore their therapeutic potential.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
